Healthcare industry reports 86 deals worth $25.5 billion in Oct 2020 EP News Bureau Nov 7, 2020 Three major deals contributes 72 per cent of total deal value
Skills and talents deficit poses biggest challenge to digital transformation in pharma EP News Bureau Nov 6, 2020 The success of digital transformation will heavily depend on employees being on board and adapting as digital transformation…
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug:… EP News Bureau Nov 5, 2020 The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…
COVID-19 is driving more supplier redundancy EP News Bureau Nov 5, 2020 The COVID-19 halo effect is driving extra funding to many small pharma companies, especially those in the infectious disease space
Long HCC pipeline marks change for previously stagnant market EP News Bureau Nov 3, 2020 Many new therapies entering the market have different mechanisms of action (MOA) and are aiming to meet needs in different…
hIVIG is good COVID-19 treatment option but faces competition from convalescent plasma EP News Bureau Oct 30, 2020 Unlike convalescent plasma, hIVIG is a plasma product that is a standardised and concentrated mixture of polyclonal antibodies…
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData EP News Bureau Oct 28, 2020 Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael…
Second wave of COVID-19 vaccines may not be needed to reach higher efficacy bar than first batch EP News Bureau Oct 24, 2020 It would be best for second wave vaccines to underscore ideal subpopulations or manufacturing and storage advantages that could…
India’s role in global supply of COVID-19 drugs and vaccines remains crucial despite IPR waiver… EP News Bureau Oct 21, 2020 WTO’s decision on IPR waiver is expected by the end of this year
Remdesivir price curbs in India make COVID-19 treatment more affordable: GlobalData EP News Bureau Oct 17, 2020 Maharashtra has fixed the price of remdesivir at Rs 2,360, 16 per cent more economical than the cheapest brand Remdac at Rs 2,800…